Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis (original) (raw)
Aapro M . (1996). The scientific rationale for developing taxoids. Anticancer Drugs7 (Suppl 2): 33–36. ArticleCAS Google Scholar
Avramis V, Nandy P, Kwock R, Solorzano M, Mukherjee S, Danenberg P et al. (1998). Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cells. Anticancer Res18: 2327–2338. CASPubMed Google Scholar
Baker SD, Zhao M, Lee CKK, Verweij J, Zabelina Y, Brahmer JR et al. (2004). Comparative pharmacokinetics of weekly and every-three-weeks docetaxel. Clin Cancer Res10: 1976–1983. ArticleCAS Google Scholar
Berchem G, Bosseler M, Mine N, Avalosse B . (1999). Nanomolar range docetaxel treatment sensitizes MCF-7 cells to chemotherapy induced apoptosis, induces G2M arrest and phosphorylates bcl-2. Anticancer Res19: 535–540. CASPubMed Google Scholar
Blagosklonny MV . (2006). Prolonged mitosis versus tetraploid checkpoint: how p53 measures the duration of mitosis. Cell Cycle5: 971–975. ArticleCAS Google Scholar
Blagosklonny MV, Robey R, Sackett DL, Du L, Traganos F, Darzynkiewicz Z et al. (2002). Histone deacetylase inhibitors all Induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity. Mol Cancer Ther1: 937–941. CASPubMed Google Scholar
Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers L . (1996). Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res56: 1851–1854. CASPubMed Google Scholar
Blajeski AL, Kottke TJ, Kaufmann SH . (2001). A Multistep Model for Paclitaxel-Induced Apoptosis in Human Breast Cancer Cell Lines. Exp Cell Res270: 277–288. ArticleCAS Google Scholar
Boudny V, Nakano S . (2002). Src tyrosine kinase augments taxotere-induced apoptosis through enhanced expression and phosphorylation of Bcl-2. Br J Cancer86: 463–469. ArticleCAS Google Scholar
Brown I, Shalli K, McDonald S, Moir S, Hutcheon A, Heys S et al. (2004). Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells. Breast Cancer Res6: R601–R607. ArticleCAS Google Scholar
Caraglia M, Giuberti G, Marra M, Di Gennaro E, Facchini G, Caponigro F et al. (2005). Docetaxel induces p53-dependent apoptosis and synergizes with farnesyl transferase inhibitor r115777 in human epithelial cancer cells. Front Biosci10: 2566–2575. ArticleCAS Google Scholar
Carmichael J, DeGraff W, Gazdar A, Minna J, Mitchell J . (1987). Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res47: 936–942. CASPubMed Google Scholar
Chang BD, Broude EV, Fang J, Kalinichenko TV, Abdryashitov R, Poole JC et al. (2000). p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene19: 2165–2170. ArticleCAS Google Scholar
Chen J-G, Yang C-PH, Cammer M, Band Horwitz S . (2003). Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res63: 7891–7899. CASPubMed Google Scholar
Consolini R, Pui C, Behm F, Raimondi S, Campana D . (1998). In vitro cytotoxicity of docetaxel in childhood acute leukemias. J Clin Oncol16: 907–913. ArticleCAS Google Scholar
Dieras V, Fumoleau P, Bourgeois H, Misset JL, Azli N, Pouillart P . (1996). Taxoids in combination chemotherapy for metastatic breast cancer. Anticancer Drugs7 (Suppl 2): 47–52. ArticleCAS Google Scholar
Escuin D, Kline ER, Giannakakou P . (2005). Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1{alpha} accumulation and activity by disrupting microtubule function. Cancer Res65: 9021–9028. ArticleCAS Google Scholar
Fabbri F, Carloni S, Brigliadori G, Zoli W, Lapalombella R, Marini M . (2006). Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: A cytometric study. BMC Cell Biol7: 6. Article Google Scholar
Fumoleau P, Chevallier B, Kerbrat P, Krakowski Y, Misset JL, Maugard-Louboutin C et al. (1996). A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC. Ann Oncol7: 165–171. ArticleCAS Google Scholar
Giannakakou P, Nakano M, Nicolaou KC, O’Brate A, Yu J, Blagosklonny MV et al. (2002). Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc Natl Acad Sci USA99: 10855–10860. ArticleCAS Google Scholar
Giannakakou P, Robey R, Fojo T, Blagosklonny M . (2001). Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene20: 3806–3813. ArticleCAS Google Scholar
Grandori C, Wu K-J, Fernandez P, Ngouenet C, Grim J, Clurman BE et al. (2003). Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev17: 1569–1574. ArticleCAS Google Scholar
Haldar S, Basu A, Croce C . (1997). Bcl2 is the guardian of microtubule integrity. Cancer Res57: 229–233. CASPubMed Google Scholar
Hernández-Vargas H, Ballestar E, Carmona-Saez P, von Kobbe C, Bañón-Rodríguez I, Esteller M et al. (2006). Transcriptional profiling of MCF7 breast cancer cells in response to 5-Fluorouracil: relationship with cell cycle changes and apoptosis, and identification of novel targets of p53. Int J Cancer119: 1164–1175. Article Google Scholar
Jordan M, Wendell K, Gardiner S, Derry W, Copp H, Wilson L . (1996). Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res56: 816–825. CASPubMed Google Scholar
Li Y, Li X, Hussain M, Sarkar F . (2004). Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray. Neoplasia6: 158–167. ArticleCAS Google Scholar
Mansilla S, Priebe W, Portugal J . (2006). Mitotic catastrophe results in cell death by caspase-dependentand caspase-independent mechanisms. Cell Cycle5: 53–60. ArticleCAS Google Scholar
Montero A, Fosella F, Hortobagyi GN, Valero V . (2005). Docetaxel for treatment of solid tumours: a systematic review of clinical data. Lancet Oncol6: 229–239. ArticleCAS Google Scholar
Moreno-Bueno G, Sanchez-Estevez C, Cassia R, Rodriguez-Perales S, Diaz-Uriarte R, Dominguez O et al. (2003). Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res63: 5697–5702. CASPubMed Google Scholar
Morse DL, Gray H, Payne CM, Gillies RJ . (2005). Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol Cancer Ther4: 1495–1504. ArticleCAS Google Scholar
Nawrocki ST, Sweeney-Gotsch B, Takamori R, McConkey DJ . (2004). The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts. Mol Cancer Ther3: 59–70. CASPubMed Google Scholar
Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P . (2002). The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat19: 607–614. ArticleCAS Google Scholar
Paoletti A, Giocanti N, Favaudon V, Bornens M . (1997). Pulse treatment of interphasic HeLa cells with nanomolar doses of docetaxel affects centrosome organization and leads to catastrophic exit of mitosis. J Cell Sci110: 2403–2415. CASPubMed Google Scholar
Roninson IB, Broude EV, Chang B-D . (2001). If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Update4: 303–313. ArticleCAS Google Scholar
Stankiewicz AR, Lachapelle G, Foo CPZ, Radicioni SM, Mosser DD . (2005). Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation. J Biol Chem280: 38729–38739. ArticleCAS Google Scholar
Tarsounas M, Munoz P, Claas A, Smiraldo PG, Pittman DL, Blasco MA et al. (2004). Telomere maintenance requires the RAD51D recombination/repair protein. Cell117: 337–347. ArticleCAS Google Scholar
Torres K, Horwitz S . (1998). Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res58: 3620–3626. CASPubMed Google Scholar
Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G . (2005). Breast cancer. Lancet365: 1727–1741. Article Google Scholar
von Kobbe C, May A, Grandori C, Bohr VA . (2004). Werner syndrome cells escape hydrogen peroxide-induced cell proliferation arrest. FASEB J18: 1970–1972. ArticleCAS Google Scholar
Wang Q, Wieder R . (2004). All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cells. Oncogene23: 426–433. ArticleCAS Google Scholar
Yoo GH, Piechocki MP, Ensley JF, Nguyen T, Oliver J, Meng H et al. (2002). Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot. Clin Cancer Res8: 3910–3921. CASPubMed Google Scholar
Zeng S, Chen YZ, Fu L, Johnson KR, Fan W . (2000). In vitro evaluation of schedule-dependent interactions between docetaxel and doxorubicin against human breast and ovarian cancer cells. Clin Cancer Res6: 3766–3773. CASPubMed Google Scholar